ERCC polymorphisms and risk of osteosarcoma: a meta-analysis.
CONCLUSIONS: The ERCC2 rs1799793 polymorphism is related to the high risk of osteosarcoma development.
PMID: 30402838 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Bone Cancers | Databases & Libraries | Drugs & Pharmacology | Gastroschisis Repair | Genetics | Osteosarcoma | Study